Clinical Trials Logo
  1. Home
  2. Scar Prevention
  3. NCT00825916

A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars

Scar Prevention Clinical Trial

Official title:
A Pilot Phase 2a Blinded, Placebo Controlled, Multicenter Parallel Group, Dose Ranging Study to Evaluate the Safety and Preliminary Efficacy of AZX100 Drug Product Following Excision of Keloids

Clinical Trial Summary

The purpose of this study was to determine the safety of AZX100 Drug Product and to determine whether it was effective in preventing or reducing re-growth of surgically removed keloid scars.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00825916
Study type Interventional
Source Capstone Therapeutics
Contact
Status Completed
Phase Phase 2
Start date March 2009
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00892723 - A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars Phase 2
Active, not recruiting NCT06312527 - Mepiform in Simultaneous Bilateral TKA N/A
Completed NCT01640912 - Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 Phase 1
Completed NCT04707131 - A Study of Single Ascending Dose of LEM-S401 in Healthy Participants Phase 1
Recruiting NCT04722705 - Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention N/A
Terminated NCT01826942 - Scar Prevention Using Fractional Carbon Dioxide Laser Treatment N/A
Completed NCT00811577 - A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients Phase 2
Completed NCT01037985 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2
Completed NCT01037413 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery Phase 2
Completed NCT01780077 - Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 Phase 1
Completed NCT01038297 - Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2